What is the Share Price of Sakar Healthcare Ltd?
- Answer Field
-
The share price of Sakar Healthcare Ltd for NSE is ₹ 271.56 and for BSE is ₹ 0.00.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, SAKAR HEALTHCARE LIMITED share price is currently at ₹ 271.56, which is down by ₹ -19.81 from its previous closing. Today, the stock has fluctuated between ₹ 265.35 and ₹ 290.00. Over the past year, SAKAR HEALTHCARE LIMITED has achieved a return of -22.55 %. In the last month alone, the return has been 15.66 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 43.42 |
Operating Expense | 38.19 |
Net Profit | 4.53 |
Net Profit Margin (%) | 10.43 |
Earnings Per Share (EPS) | 2.08 |
EBITDA | 12.01 |
Effective Tax Rate (%) | 17.15 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.
The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.
The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote d'ivoire.
In 2005, the Company started commercial production for Plant - 1 which was established for production of Liquid Orals; in 2007, it started exporting its products overseas; started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet in 2008. Further, it started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials.
In 2012, it started commercial production for Plant - 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.
In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022-23, the Company started commercialization with Oncology product post receiving WHO GMP certification.
The share price of Sakar Healthcare Ltd for NSE is ₹ 271.56 and for BSE is ₹ 0.00.
The market cap of Sakar Healthcare Ltd for NSE is ₹ 5,90.64 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 374.50 and ₹ 210.10 and for BSE is ₹ 0.00 and ₹ 0.00.
You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -22.55%.
Sakar Healthcare Ltd share price is for NSE ₹ 271.56 & for BSE ₹ 0.00 as on Apr 30 2025 03:30 PM.
The market cap of Sakar Healthcare Ltd for NSE ₹ 5,90.64 & for BSE ₹ 0.0 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Sakar Healthcare Ltd share is 40.11.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Sakar Healthcare Ltd share is 126.28.
You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a demat account.
To buy Sakar Healthcare Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Sakar Healthcare Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found